Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cimetidine does not stimulate human T lymphocyte functions in vitro

B Charpentier, P Lang, B Martin

    Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
    |January 1, 1982
    PubMed
    Summary

    Cimetidine, an H2-receptor antagonist, did not affect T cell functions in human lymphocytes. This study found no evidence of Cimetidine enhancing or suppressing cell-mediated immunity in vitro.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    COVID-19 epidemic phases: Criteria, challenges and issues for the future.

    Bulletin de l'Academie nationale de medecine·2020
    Same author

    [Covid-19 epidemic phases: Criteria, challenges and issues for the future].

    Bulletin de l'Academie nationale de medecine·2020
    Same author

    Efficacy of Prolonged- and Immediate-release Tacrolimus in Kidney Transplantation: A Pooled Analysis of Two Large, Randomized, Controlled Trials.

    Transplantation proceedings·2017
    Same author

    Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
    Same author

    Daclizumab Versus Rabbit Antithymocyte Globulin in High-Risk Renal Transplants: Five-Year Follow-up of a Randomized Study.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
    Same author

    Articulating the value of health research.

    QJM : monthly journal of the Association of Physicians·2014

    Area of Science:

    • Immunology
    • Pharmacology

    Background:

    • Cimetidine is an H2-receptor antagonist with potential immunomodulatory effects.
    • Previous studies suggested Cimetidine might increase cell-mediated immunity.

    Purpose of the Study:

    • To investigate the in vitro effects of Cimetidine on human T cell functions.
    • To determine if Cimetidine has immunoproliferative or immunostimulative effects.

    Main Methods:

    • Human peripheral blood lymphocytes were cultured with Cimetidine.
    • Cultures were stimulated with mitogens, alloantigens, and xenoantigens.
    • T cell proliferation and helper/cytotoxic T cell generation were assessed kinetically.

    Main Results:

    • Cimetidine exhibited no immunoproliferative or immunostimulative effects on T cells.

    Related Experiment Videos

  • The generation of helper and cytotoxic T cells remained unmodified by Cimetidine.
  • These findings contradict previous reports on Cimetidine's immunostimulatory properties.

    • Conclusions:

    • Cimetidine does not enhance or suppress in vitro T cell functions in normal human lymphocytes.
    • The study failed to confirm previous claims of Cimetidine increasing cell-mediated immunity.
    • Further research may be needed to fully elucidate Cimetidine's role in immune responses.